Health & Biotech
Health & Biotech
Zoono is a $24m company. It just sold $33m worth of product
Health & Biotech
Dr Boreham’s Crucible: Rhythm Biosciences is ready to trial its hands-off poo test
Health & Biotech
Health: Genetic Technologies has two new tests that check your risk for cancers
Health & Biotech
‘The sky is the limit’: Here’s what Orthocell chief Paul Anderson had to say after that meteoric rise
Health & Biotech
No Spin: The health election promises that will affect ASX stocks
Health & Biotech
Denver just decriminalised magic shrooms; is it only a matter of time before ASX biotechs start tripping too?
Health & Biotech
Health: Pharmaxis on verge of $14.3m payout after FDA close call on Bronchitol
Health & Biotech
Check-up: What’s happening with ASX small cap health stocks?
Health & Biotech
The caps will stay, but here’s how Labor’s R&D reform might fire up Aussie innovation again
Health & Biotech
Health: Patients are saying Orthocell has fixed their damaged nerves, shares go ballistic
Health & Biotech
MGC births first cannabis products into the UK
Health & Biotech
Health: Actinogen’s Alzheimer’s treatment comes up short, stock crashes 70pc
Health & Biotech
The total market cap of small cap ASX medtechs grew 57pc in the past year
Health & Biotech
Dr Boreham’s Crucible: Is Cynata Therapeutics’ Fujifilm partnership all puff and no blow?
Health & Biotech
Epilepsy and dementia sufferers across the globe to benefit from new MGC Pharma agreements
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.